Swee Lay Thein, M.D., MD

Rare Disease / Clinical Research

National Heart, Lung, and Blood Institute (NHLBI)

BETHESDA, MD

PI on 12 trialsNPI: 1992697643

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Drug- or toxin-induced pulmonary arterial hypertension
Hemoglobinopathy
Sickle cell disease
Sickle cell-beta-thalassemia disease
Beta-thalassemia
Sickle cell anemia
Genetic hemoglobinopathy
Semicircular canal dehiscence syndrome
Coronary artery congenital malformation

Clinical trials (12)

NCT05904093
NCT03049475
NCT00011648
NCT04610866
NCT01441141
NCT03685721
NCT04000165
NCT05675436
NCT00047996
NCT00367523
NCT00081523
NCT03572036

Verify independently

ClinicalTrials.gov PI search for Swee Lay Thein, M.D.
NPPES NPI registry entry

Other specialists for Drug- or toxin-induced pulmonary arterial hypertension

Peers ranked by clinical-trial PI role, publications, and verification quality.

Andjela Kusic-Pajic, MD
Actelion
Eric Austin, MD
Vanderbilt Medical Center
Ekkehard Grünig, MD
Thoraxclinic at the University of Heidelberg
Sudarshan Rajagopal, MD, PhD, M.D
Duke Health System
NC
Nicholas S Hill, MD
Tufts Medical Center
Richard Aranda
Gossamer Bio Inc.
Horst Olschewski, MD
Medical University of Graz
Mamta Fuloria, MD, MD
Montefiore Medical Center
NJ

See all specialists for Drug- or toxin-induced pulmonary arterial hypertension →

← Back to specialists directory